Sarepta Therapeutics (SRPT) Receivables Refunds: 2023-2025
Historic Receivables Refunds for Sarepta Therapeutics (SRPT) over the last 2 years, with Sep 2025 value amounting to $14.3 million.
- Sarepta Therapeutics' Receivables Refunds rose 25.20% to $14.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.3 million, marking a year-over-year increase of 25.20%. This contributed to the annual value of $13.1 million for FY2024, which is 91.37% up from last year.
- As of Q3 2025, Sarepta Therapeutics' Receivables Refunds stood at $14.3 million, which was up 97.40% from $7.2 million recorded in Q2 2025.
- In the past 5 years, Sarepta Therapeutics' Receivables Refunds ranged from a high of $14.3 million in Q3 2025 and a low of $6.9 million during Q4 2023.
- Moreover, its 3-year median value for Receivables Refunds was $8.4 million (2024), whereas its average is $9.8 million.
- Per our database at Business Quant, Sarepta Therapeutics' Receivables Refunds skyrocketed by 91.37% in 2024 and then dropped by 13.92% in 2025.
- Quarterly analysis of 3 years shows Sarepta Therapeutics' Receivables Refunds stood at $6.9 million in 2023, then skyrocketed by 91.37% to $13.1 million in 2024, then climbed by 25.20% to $14.3 million in 2025.
- Its Receivables Refunds stands at $14.3 million for Q3 2025, versus $7.2 million for Q2 2025 and $7.0 million for Q1 2025.